Philadelphia Spotlights

SPOTLIGHT: Big4Bio:Philadelphia 2020 Year-in-Review

/ / ,

Welcome to the 2020 Big4Bio Year-in-Review for the Philadelphia area! We hope you enjoy looking back on 2020’s top stories, deals, and M&A that went down in Philadelphia’s research, pharma, and biotech sectors as we head into 2021. Here’s what you’ll find inside the Year-in-Review 2020 report: Facts about Greater Philadelphia’s life sciences industry The […]

Read More

Spotlight Q&A: TFF Pharmaceuticals – Innovative Drug Formulation May Expand Geographic Reach of COVID-19 Vaccines and Treatments

/

LaVoieHealthScience Client Spotlight Following is a Q&A with Glenn Mattes, President, CEO and Director of TFF Pharmaceuticals (Nasdaq: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform. Welcome to Big4Bio, Mr. Mattes. Can you share with our readers what is important about […]

Read More

Spotlight Q&A: John Hallinan, Chief Development Officer, Danforth Advisors

/

John Hallinan is the newly-named Chief Development Officer of Danforth Advisors, the life science industry’s leading resource for operational accounting, finance support and strategic CFO advisory. He was previously Chief Business Officer at Massachusetts Biotechnology Council (MassBio), representing the world’s premier life sciences hub, where he led efforts to catalyze early-stage innovation. He has more […]

Read More

Big4Bio Q&A: Dror Bashan, CEO of Protalix BioTherapeutics

/

LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]

Read More

Spotlight: 3.0 University Place

/

“In many ways, this project (3.0 University Place) is the most responsive to the needs of Philly’s burgeoning biotech and advanced life sciences sector” – 2020 PIDC/Commerce Department Life Science Report   About 3.0 University Place: 3.0 University Place — a 250,000+ sq ft, life sciences-enabled building (commercial lab and office trophy building) with LEED […]

Read More

Spotlight: Sikich — A Formula for Life Science Success

/

Sikich LLP is a 1000 member business advisory firm that offers technology and accounting services to a broad array of companies. In operation for more than 35 years, about 10 years ago the company started offering its services to life sciences companies, tailored to fit their specific needs. Big4Bio editor Marie Daghlian recently met virtually […]

Read More

Big4Bio:Philadelphia COVID-19 Resource Page

/

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]

Read More

SPOTLIGHT: Big4Bio:Philadelphia 2019 Year-in-Review

/

Welcome to the first-ever Big4Bio Year-in-Review for the Philadelphia area! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in Philadelphia’s research, pharma, and biotech sectors as you look to a productive 2020. The Greater Philadelphia region has finally come into its own in the life science world! […]

Read More

Big4Bio Interview with Halloran Consulting Group’s Laurie Halloran and Katie McCarthy

/

Boston-based Halloran Consulting Group offers senior-level expertise to life science companies as they navigate the regulatory, clinical, and operational challenges at each stage of their development. At the beginning of October, Halloran announced several promotions in its organization, and the expansion of operations in San Diego, setting up a West Coast office there to better […]

Read More

Spotlight: Catching Up With CO.DON AG CEO, Ralf Jakobs

/

LaVoieHealthScience Client Spotlight: CO.DON CEO, Ralf Jakobs — Advancing Autologous Human Cell Transplants   Can you provide a brief overview of CO.DON and its focus? CO.DON is focused on the development, production and marketing of cell-based products for joint-preserving, regenerative treatment of articular cartilage defects. That’s all we do and where we have built our […]

Read More